BATF2 and glioblastoma: In this study, we demonstrate that loss of BATF2 does increase the expression of proliferation markers in Batf2−/− astrocytes; however, this effect was observed in otherwise normal cells that lack many of the genetic mutations detected in glioblastoma (49, 50).